TechForce Robotics, Inc., the acting subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), has completed the initial deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics. This marks the company's first operational entry into pharmaceutical and laboratory automation, extending its Robotics-as-a-Service (RaaS) platform beyond hospitality into a sector facing similar efficiency challenges.
The deployment fulfills Phase 1 objectives under a joint development agreement designed to evaluate robotics and AI-enhanced systems for future GMP-regulated pharmaceutical manufacturing and laboratory workflows. The agreement aims to demonstrate how automation can support operational scalability without disrupting tightly regulated processes. A new strategic alliance with JJ Enterprise adds advanced manufacturing, machine vision, and precision engineering expertise that could support the expansion of high-precision AI-driven applications.
Laboratory and pharmaceutical operations increasingly face the same challenge that has accelerated automation across industries from manufacturing to hospitality: how to improve efficiency while freeing highly trained personnel to focus on higher-value work. Researchers, technicians, and production staff often spend significant time on routine logistics tasks that, while necessary, do not directly advance scientific work, product development, or manufacturing output. As labor costs rise and productivity demands grow, pharmaceutical and biotechnology organizations are exploring automation solutions capable of supporting operational scalability without disrupting tightly regulated workflows.
TechForce Robotics is positioning itself to address that opportunity by extending its RaaS platform into laboratory environments. The LIM-E robot is designed to handle routine material transport and logistics within laboratories, potentially reducing the time scientists spend on non-value-added activities. The company's experience in hospitality automation, where robots are used for tasks like food delivery and cleaning, provides a foundation for adapting these systems to the more stringent requirements of pharmaceutical settings.
The partnership with Oncotelic Therapeutics and the strategic alliance with JJ Enterprise signal TechForce's commitment to expanding its footprint in life sciences automation. As the pharmaceutical industry continues to seek ways to increase productivity while maintaining compliance with GMP standards, robotics and AI solutions like those offered by TechForce could play a critical role in modernizing laboratory operations.
